Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Dihydroergotamine (DHE) – Then and Now: A Narrative Review.

< BACK TO ARCHIVE


Papers: 16 Nov 2019 - 22 Nov 2019


Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2020 Jan


Headache


http://www.ncbi.nlm.nih.gov/pubmed/31737909?dopt=Abstract


60


1

Dihydroergotamine (DHE) – Then and Now: A Narrative Review.

Authors

Dihydroergotamine (DHE) - Then and Now: A Narrative Review.
Silberstein SD, Shrewsbury SB, Hoekman J
Headache. 2020 Jan; 60(1):40-57.
PMID: 31737909.

Abstract

To provide a narrative review of clinical development programs for non-oral, non-injectable formulations of dihydroergotamine (DHE) for the treatment of migraine.
Read This Paper